Patients on the weight-loss drug Zepbound regained weight almost one year after stopping treatment, according to a study published this week in the Journal of the American Medical Association.

The Broadway icon said he’s a “great believer” in the weight-loss medication, which helped him after he weighed 310 ... the weight-loss medication Zepbound, with Page Six.

A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.

GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better ... OSA and obesity. After taking tirzepatide (Zepbound) for a year, these ...

Patients taking a compounded alternative to Eli Lilly's weight loss ... in a statement that after two years of being in shortage, tirzepatide — the active ingredient in Zepbound and its ...

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

Those who took Zepbound also lost more weight than the placebo group after one year. Their symptom improvement was likely thanks to their weight loss, the FDA said. Zepbound is a glucagon-like ...

The proportion of obese Indians has risen from 25 per cent in 2013 to 40 per cent in 2023, highlighting the need for ...

Tirzepatide, sold under the brand names Zepbound and Mounjaro ... diabetes taking once-weekly tirzepatide experienced 15% weight loss after 72 weeks. A 2023 study found that individuals with ...

Eli Lilly's stock tumbled 8% on Tuesday after it forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street ...

Participants using Zepbound lost 50.3 lbs ... or some adults with overweight who also have weight-related medical problems to lose excess body weight and keep the weight off.